Current Report · Items 1.01, 8.01, 9.01 · 8-K
Birchtech Corp.
Entry into a Material Definitive Agreement · Other Events
Item 1.01 Entry into a Material Definitive Agreement. On February 25, 2026, Birchtech Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lake Street Capital Markets, LLC, as representative of the several underwriters named therein (collectively, the “Underwriters”), relating to the public offering of 6,250,000 shares (the “Shares”) of the Company’s com…
Filed Feb 27, 2026Accepted Feb 27, 2026, 4:01 PM ESTCIK 728385Accession 0001104659-26-021534
Company context
We are a provider of specialty activated carbon technologies, delivering innovative solutions for air and water purification. We provide patented and proprietary technologies for mercury emissions capture to the coal-fired utility sector, and are developing disruptive water purification technologies with a specialization on forever chemicals such as PFAS and PFOS.
Current securities
Historical securities (5)
Registered securities in this filing
BIRCHTECH CORP. · 8-K · Filed 2026-02-27
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $0.001 per share
- Symbol
- BCHT
- Exchange
- NYSEAMER
- Classification
- COMMON
Filing context
Context: AsOf2026-02-25
Dimensions: Not supplied
Accession 000110465926021534 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 1.01, 8.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive
Agreement.
On February 25, 2026, Birchtech Corp. (the “Company”) entered
into an underwriting agreement (the “Underwriting Agreement”) with Lake Street Capital Markets, LLC, as representative of
the several underwriters named therein (collectively, the “Underwriters”), relating to the public offering of 6,250,000 shares
(the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price per share of $2.40 (the
“Offering Price”). Pursuant to the Underwriting Agreement, the Company also granted the Underwriters a 30-day option to purchase
up to an additional 937,500 shares of common stock at the Offering Price, less any underwriting discounts and commissions.
The offering closed on February 27, 2026. Net proceeds from the offering
were approximately $13.1 million (and will be approximately $15.2 million if the Underwriters exercise their option to purchase additional
shares of common stock in full) after deducting the underwriting discounts and commissions and other estimated offering expenses payable
by the Company. The Company intends to use the net proceeds of the offering, together with the Company’s existing cash, for, among
other things, continuing operating expenses, working capital and other general corporate purposes. The Company’s directors and
executive officers entered into lock-up agreements, pursuant to which they agreed with the Underwriters not to offer for sale, issue,
sell, contract to sell, pledge or otherwise dispose of any of the Company’s common stock or securities convertible into common
stock for a period of 90 days after February 25, 2026, subject to certain exceptions. The Company’s Chief Executive Officer purchased
an aggregate of $750,000 of shares of common stock in the offering (an aggregate of 312,500 shares) and has represented to the Company
that such purchase was solely for investment purposes.
The Shares were offered pursuant to a Registration Statement on Form
S-1, as amended (File No. 333-292701), which was declared effective by the U.S. Securities and Exchange Commission (the “SEC”)
on February 17, 2026 (the “Registration Statement”), including the preliminary prospectus included therein. A final prospectus
relating to the offering was filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”),
with the SEC on February 27, 2026.
The Underwriting Agreement contains customary representations, warranties
and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including
for liabilities under the Securities Act, other obligations of the parties and termination provisions. A copy of the Underwriting Agreement
is attached as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference, and the description of the Underwriting
Agreement herein is qualified in its entirety by reference to such exhibit.
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On February 26, 2026, the Company issued a press release announcing
the pricing of the offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Description
Number
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
1.1 Underwriting Agreement, dated as of February 25, 2026, between the Company and Lake Street Capital Markets, LLC, as representative of the several underwriters named therein
99.1 Press Release, dated February 26, 2026
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
-2-
Filed exhibits (1)
EX-99.1 (by filename) tm267456d1_ex99-1.htmEX-99.1
3
tm267456d1_ex99-1.htm
EXHIBIT 99.1
Exhibit 99.1
Birchtech Announces Pricing
of $15 Million Public Offering and Uplisting to NYSE American Stock Exchange
CORSICANA, Texas
- February 26, 2026 - Birchtech Corp. (NYSE American: BCHT) (TSX: BCHT) (“Birchtech” or the “Company”),
a leader in specialty activated carbon technologies for sustainable air and water treatment, today announced the pricing of an underwritten
public offering of 6,250,000 shares of its common stock at a public offering price of $2.40 per share, before deducting underwriting discounts
and commissions and offering expenses, for aggregate gross proceeds of approximately $15.0 million.
The Company intends to use the net proceeds from
the offering, together with the Company’s existing cash, for, among other things, continuing operating expenses, working capital
and other general corporate purposes. The Company has also granted the underwriters a 30-day option to purchase up to an additional 937,500
shares of common stock at the public offering price solely to cover over-allotments, if any. The offering is expected to close on or about
February 27, 2026, subject to the satisfaction or waiver of customar…
Open exhibit ↗